Home Top Movers Why Stealth BioTherapeutics Corp (MITO) stock price fluctuated on Tuesday?

Why Stealth BioTherapeutics Corp (MITO) stock price fluctuated on Tuesday?

Stealth BioTherapeutics Corp (MITO) shares were rose 6.08% in after-hours on Tuesday, July 13, 2021, and closed the trading at $1.57 per share. earlier in the morning session, MITO’s stock lost 5.13% to close Tuesday’s session at $1.48. MITO shares have fallen 20.00% over the last 12 months, and they have moved down 2.63% in the past week. Over the past three months, the stock has gained 16.54%, while over the past six months, it has shed 0.68%.

>> 7 Top Picks for the Post-Pandemic Economy << 

Let’s discuss its recent news and development briefly.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Are Better days ahead for Stealth BioTherapeutics?

According to Zacks Equity Research, Stealth BioTherapeuticsCorp has been struggling lately, but the selling pressure may be coming to an end soon. That is because MITO recently saw a Hammer Chart Pattern but wait what this term means?

Read More

A hammer chart pattern is a technical indicator that is used in candlestick charting. The hammer appears when a stock tumbles during the day but then finds strength at some point in the session to close near or above its opening price. This forms a candlestick that resembles a hammer, and it can suggest that the market has found a low point in the stock and that better days are ahead.

Stealth Bio joined Rare Disease Company Coalition

On July 7, 2021, Stealth BioTherapeutics joined the Rare Disease Company Coalition, an alliance of life science companies committed to discovering, developing, and delivering rare disease treatments for the patients they collectively serve.

The Chief Executive Officer of StealthReenie McCarthy said that they are very excited to be a part of the first-of-its-kind Rare Disease Company Coalition, which is focused on supporting rare disease patients through the development of innovative therapeutics.He further said that he is looking forward to working with the other inspiring companies to foster a greater understanding of the unique challenges and circumstances associated with the development of rare disease treatments.

Orphan drug designation for Elamipretide

On June 1, 2021, European Medicines Agency (EMA) granted orphan drug designation (ODD) for elamipretide, which is used for the treatment of Barth syndrome, an ultra-rare genetic condition.

Participation in the recent health conference

Stealth BioTherapeutics Corp participated virtually in Jefferies Healthcare Conference which held on Tuesday, June 1, 2021, at 3:00 p.m. ET.

 Recent financial results

On May 18, 2021, Stealth BioTherapeutics Corp announced its financial results for the quarter ended March 31, 2021.

Q1 2021 financial highlights

  • Research and Development (R&D)expenses were $6.1 million in Q1 2021, compared to $9.8 million in Q1 2020.
  • General and Administrative (G&A) expenses were $5.0 million for the reported quarter, compared to $5.2 million for the same period in 2020.
  • As of March 31, 2021, the company had cash and cash equivalents totalled $32.1 million compared to $32.8 million on December 31, 2020
  • Stealth BioTherapeutics suffered a net loss of $7.7 million, or $0.01basic and diluted net loss per ordinary share in Q1 2021 compared to$15.5 million, or $0.04 basic and diluted net loss per ordinary share in Q1 2020.

    >> 7 Top Picks for the Post-Pandemic Economy << 

Conclusion

The analyst thinks that good days are ahead for the MITO and it might be the reason behind its price fluctuation on Tuesday. We hope that MITO stock will stabilize in the coming days as predicted by the analysts.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Smith Micro Develops Inc. (SMSI) stock soars during current market trading. Here’s to know why?

Smith Micro Develops Inc. (NASDAQ: SMSI) stock surged by 2.39% during the current market trading session. Smith Micro creates software that simplifies and improves...

Drive Shack Inc. (DS) stock soars during after-hour trading, followed by no recent update

Drive Shack Inc. (NASDAQ: DS) stock declined by 3.94% at last close while the DS stock-price surged by 7.38% in the after-hour session. Drive...

SPX Flow Inc. (FLOW) stock surged during current market. Here’s why the stock is sky-rocketing?

SPX Flow Inc. (NASDAQ: FLOW) stock gained by 24.24% in the current market trading session. SPX FLOW, based in Charlotte, works to make the...

Platinum Group Metal Ltd. (PLG) stock surges during after-market trading. Here’s to know what’s happening?

Platinum Group Metal Ltd. (NASDAQ: PLG) stock declined by 8.54% at last close whereas the PLG stock price gains by 7% in the after-market...

TD Holdings Inc. (GLG) stock gains during current market trading. Here’s the recent update

TD Holdings Inc. (NASDAQ: GLG) stock gains by 5.01% in the current market trading session. TD Holdings, Inc. is a service provider in China...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

NeuroMetrix Inc. (NURO) stock plunged during pre-market. Let’s find out why?

NeuroMetrix Inc. (NASDAQ: NURO) stock gained by 18.89% at last close while the NURO stock price losses by -4.12% in the pre-market trading session....

Related News

Veoneer Inc. (VNE) stock shows massive gains during pre-market. What’s driving it high?

Veoneer Inc. (NASDAQ: VNE) stock decline by 1.82% at the last close whereas the VNE stock price gains by 55.19% in the pre-market trading...

AnPac Bio-Medical Sciences Inc. (ANPC) stock soars during pre-market. Here’s what you should know?

AnPac Bio-Medical Sciences Inc. (NASDAQ: ANPC) stock declined by 4.98% at last close however the ANPC stock price gains by 6.96% in the pre-market...

Endeavour Silver Corp. (EXK) stock surged during pre-market trading. Here’s what you should know?

Endeavour Silver Corp. (NASDAQ: EXK) stock declined by 4.97% at the last close whereas the EXK stock price gains by 3.56% in the pre-market...

Here is why Amneal Pharmaceuticals Inc (AMRX) stock soared on Monday?

Amneal Pharmaceuticals Inc. (AMRX) shares rose 7.18% in after-hours on Monday, July 19, 2021, and closed at $4.63 per share. Earlier in the morning,...

Why Applied DNA Sciences Inc. (APDN) stock had a bad Friday?

Applied DNA Sciences Inc. (APDN) shares fell 5.27% in after-hours on Friday, July 16, 2021, at $5.03 per share. Earlier, APDN's stock lost 2.93%...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam